PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.57%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
28.62%
Positive 5Y CAGR while CX is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
21.92%
Positive 3Y CAGR while CX is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
41.80%
Below 50% of CX's 9269.06%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-10.75%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-40.42%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
671.79%
5Y net income/share CAGR above 1.5x CX's 357.94%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
685.96%
3Y net income/share CAGR above 1.5x CX's 224.56%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
-24.85%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
31.40%
Positive 5Y equity/share CAGR while CX is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
18.22%
3Y equity/share CAGR above 1.5x CX's 4.97%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
9.31%
Dividend/share CAGR of 9.31% while CX is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
45.93%
3Y dividend/share CAGR of 45.93% while CX is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.